Covid 19 Analysis Coronavirus COVID-19's Impact: Since the emergence of the COVID-19 virus in December 2019, the disease has spread to nearly every country on the planet, prompting the World Health Organization to declare it a public health emergency. The global effects of the coronavirus illness 2019 (COVID-19) are already being felt, and the dental sleep medicine market trends will be substantially impacted in 2021. Flight cancellations, travel restrictions, and quarantines, restaurants closing, all indoor/outdoor events being limited, over forty nations declaring states of emergency, major supply chain slowdowns, and stock market volatility have all been impacted by the COVID-19 epidemic.
In October 2023, a clinical-stage pharmaceutical company specializing in oral pharmacologic therapies for obstructive sleep apnea (OSA) and other sleep disorders called Apnimed, Inc. announced a new partnership. They formed a joint venture with Shionogi & Co., Ltd., one of the world’s leading pharmaceutical companies which is based in Japan.
In June 2023, Torch Dental, a major dental procurement platform, partnered with the American Academy of Dental Sleep Medicine (AADSM). This move was widely regarded as an important milestone since each party brought its own knowledge base together to enhance dental sleep medicine through innovative solutions, education, and practice management that will help AADSM members gain some unique benefits.
New West Dental Lab launched EndSnorZ Sleep Appliance in December 2022 as it seeks to diversify its range of mandibular advancement devices (MADs). This latest inclusion gives dentists using 3D-printing technology the possibility of producing individualized products for patients. The appliance offers adjustable increments of up to 0.5 mm over a 10 mm range, thereby providing specific treatment options that are both precise and tailored to meet each patient’s needs.
In the projection period of 2021 to 2028, the dental sleep medicine market will benefit from increased research and development, as well as linked solutions and cloud-based systems, as well as personalized and customized solutions.
Some factors that may impede the growth of the dental sleep medicine market include a lack of patient awareness and expensive treatment prices.
The high cost and scarcity of sleep laboratories, as well as their lack of efficacy and efficiency, would restrict the expansion of the dental sleep medicine market, whereas inadequate standardization, lack of knowledge, and discomfort may provide a challenge to the dental sleep medicine market's growth.
Cumulative Growth Analysis
Unmet medical demands are driving the growth of the dental sleep medication industry. Obstructive sleep apnea affects over 30 million individuals in the United States, according to the American Academy of Dental Sleep Medicine. Sleep is harmed by sedentary lifestyles, extended working hours, noise exposure, and light pollution such as the usage of bright neon lights. Due to its safety, efficiency, and efficacy when compared to procedures and medicines, positive air pressure treatment has the greatest dental sleep medicine market share.
The gold standard in dental sleep medicine diagnosis is polysomnography and respiratory polygraphy. However, because of their simplicity of use, efficiency, and accuracy, the emergence of portable and home-based devices is threatening their market dominance. The primary reason for the increase in efficiency and accuracy is the employment of sophisticated software in these products. Oximetry is more portable and quicker, but the findings are less sensitive and accurate.
Value Chain Analysis
According to the reports, the global dental sleep medicine market is segmented on the basis of treatment, diagnostics, end-user, and region. Positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, medicines, surgery, and other devices are all part of the treatment section. Polysomnography and respiratory polygraphy, home oximetry, and actigraphy are all part of the diagnostics section. The dental sleep medicine market is divided into three categories based on the end-user: hospitals, sleep labs, and homes. In 2016, the treatment segment had the biggest dental sleep medicine global market share of 61.42 percent, and it is anticipated to increase at a CAGR of 8.74 percent from 2016 to 2022. In 2016, hospitals and sleep laboratories had the biggest dental sleep medicine global market share of 57.1 percent, while North America had the largest market share of USD 2,849.44 million.
Dental Sleep Medicine Market Segment Insights
The dental sleep medicine market is segmented on the basis of treatment, diagnostics, end-user, and region. The global dental sleep medicine market is expected to witness decent growth during the forecast period.
Based on the application, the dental sleep medicine market is segmented into positive airway pressure (PAP) therapy, oral and nasal devices, airway systems, medicines, surgery, and other devices.
Based on the propulsion types, the dental sleep medicine market is segmented into hospitals, sleep labs, and homes.
Regional Analysis
According to the reports, on the basis of region, the global dental sleep medicine market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2016, North America was the world's largest market for dental sleep medicine. Because of its high per capita income, superior reimbursement policies for medical equipment, and larger healthcare industry, the United States leads the North American market. The expansion of the North American market is also fueled by the concentration of major medical device makers in the United States. In 2016, Europe was the world's second-largest market for dental sleep medicine. The emerging regions, notably the Asia Pacific and the Middle East, and Africa, are projected to see the greatest growth for high-tech and low-tech dental sleep medication products throughout the projection period due to huge unmet demand.
Competitive landscape
The global dental sleep medicine market is highly fragmented due to the presence of prominent players in the market. Mergers, R&D, partnerships, and other tactics used by market players to get a foothold in this Market organizations are examples of specific methods used by market players to gain a foothold in the Dental Sleep Medicine Market.
Major Key Players
The following report comprises of –
2018, April- The American Academy of Dental Sleep Medicine, a leading national dentists' organization, has announced the AADSM Mastery Program, which will ensure that dentists have the necessary skills and training to provide patients with sleep-related breathing disorders such as snoring and obstructive sleep apnea (OSA) with proper oral appliance therapy (OAT).
| Report Attribute/Metric | Details |
| Â Â Market Size | Â Â 2032: USD 9.1 Billion |
| Â Â CAGR | Â Â 2024-2032: 7.40% |
| Â Â Base Year | Â Â 2023 |
| Â Â Forecast Period | Â Â 2024-2032 |
| Â Â Historical Data | Â Â 2021 |
| Â Â Forecast Units | Â Â Value (USD Billion) |
| Â Â Report Coverage | Â Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Â Â Segments Covered | Treatment, Diagnostics and End user |
| Â Â Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Â Â Key Vendors | Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare, Drive DeVilbiss Healthcare, Curative Medical Inc., Apex Medical Corporation, BMC Medical Co. Ltd., Becton, Dickinson and Company |
| Â Â Key Market Opportunities | The North American market is led by the U.S. due to high per capita income, better reimbursement policy for medical devices, and larger healthcare market Concentration of major medical device manufacturers in the U.S. Fastest growth for high-tech and low-tech dental sleep medicine products in Asia Pacific and the Middle East & Africa |
| Â Â Key Market Drivers | Unmet medical needs and rising prevalence of sleep apnea |
Dental Sleep Medicine Market Highlights:
Frequently Asked Questions (FAQ) :
North America is predicted to lead the Dental Sleep Medicine Market.
Sleep laboratories and hospitals will dominate the Dental Sleep Medicine Market.
Unmet medical needs and rising prevalence of sleep apnea are boosting market growth.
High treatment cost may limit market growth.
Specific strategies adopted by market players to create a foothold in the Dental Sleep Medicine Market include mergers, R&D, collaborations, and others.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
